These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 3384000)
1. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Zetterström T; Sharp T; Collin AK; Ungerstedt U Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000 [TBL] [Abstract][Full Text] [Related]
2. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297 [TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237 [TBL] [Abstract][Full Text] [Related]
4. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Zetterström T; Sharp T; Ungerstedt U Eur J Pharmacol; 1986 Dec; 132(1):1-9. PubMed ID: 3816961 [TBL] [Abstract][Full Text] [Related]
5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. Robertson GS; Damsma G; Fibiger HC J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381 [TBL] [Abstract][Full Text] [Related]
7. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis. Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456 [TBL] [Abstract][Full Text] [Related]
8. An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis. Sharp T; Zetterström T; Ungerstedt U J Neurochem; 1986 Jul; 47(1):113-22. PubMed ID: 3711893 [TBL] [Abstract][Full Text] [Related]
9. Effects of reserpine and antidepressants on dopamine and DOPAC (3,4-dihydroxyphenylacetic acid) concentrations in the striatum, olfactory tubercle and median eminence of rats. Fekete MI; Szentendrei T; Herman JP; Kanyicska B Eur J Pharmacol; 1980 Jun; 64(4):231-8. PubMed ID: 7389821 [TBL] [Abstract][Full Text] [Related]
11. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens. Ichikawa J; Meltzer HY J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347 [TBL] [Abstract][Full Text] [Related]
12. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates of rats. Nielsen JA; Chapin DS; Moore KE Life Sci; 1983 Nov; 33(19):1899-907. PubMed ID: 6645784 [TBL] [Abstract][Full Text] [Related]
14. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs. Radhakishun FS; Korf J; Venema K; Westerink BH Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209 [TBL] [Abstract][Full Text] [Related]
15. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929 [TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Nomikos GG; Damsma G; Wenkstern D; Fibiger HC Synapse; 1990; 6(1):106-12. PubMed ID: 1697988 [TBL] [Abstract][Full Text] [Related]
17. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545 [TBL] [Abstract][Full Text] [Related]
18. Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study. Adachi YU; Watanabe K; Satoh T; Vizi ES Br J Anaesth; 2001 Jun; 86(6):837-45. PubMed ID: 11573593 [TBL] [Abstract][Full Text] [Related]
19. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. Snyder GL; Keller RW; Zigmond MJ J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978 [TBL] [Abstract][Full Text] [Related]
20. The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid. Juorio AV Br J Pharmacol; 1982 Nov; 77(3):511-5. PubMed ID: 7139200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]